Teva Pharmaceutical Finance Netherlands II BV (TEVA) 2021-1

CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
UZU3,254.0001.6Oct-23MjxwxbLl2YY--StffpGdcZlj 4m3.75-3875%4213.75%-614.00000
SDN6,255.0007.8Mar-14IqxjinNl2BB--TmvuwHeeTjfv 4p4.3755-4.5%4655.13%-543.00000
NJC6,135.0009.1Nov-17JgzbenFl2BB--EawczCezYvpm qrhq 4j4.75-4.875%3534.75%-504.00000
ZKO4,284.0003.6Mar-17DwhjvpCo2RR--ZhwwqUln-5.125-5.25%3705.13%-108.00000
Tranche Comments
5.5 nt: First Pay: 2022-05-09; Redemption: 2027-02-09; Registration: Ojcukmjzje; Comments: ZRR1cm 4.75% fnm 5.5cq (5/09/27) hj 100.00, cld 4.75%. Rnquhdw M+353cn. TTM M+50cn. 144L MZRKVw 88167LLV6. MdM 101%; 7.5 ne: First Pay: 2022-05-09; Redemption: 2027-02-09; Registration: Ipjeacpppp; Comments: LSG1ws 5.125% vjs 7.5mx (5/09/29) pt 100.00, maf 5.125%. Sjxepfi D+370wj. SEC D+50wj. 144S CLSJJi 88167SSR4. CeC 101%; 5.5 cb: First Pay: 2022-05-09; Redemption: 2027-02-09; Registration: Ffwpncflfw; Comments: MEJ1.1hm 3.75% cvm 5.5qq (5/09/27) sz 100.00, qfx 3.75%. Tvqnsxa +421hv. RRV DZD+50hv. CTCMa PT2406607098. VmV 101%; 8.5 hp: First Pay: 2022-05-09; Redemption: 2027-02-09; Registration: Zkbgicktkj; Comments: YVR1.5nm 4.375% fsm 8.5yc (5/09/30) qi 100.00, yia 4.375%. Fscbqap +465ns. UJE PGL+50ns. ZFZYp RF2406607171. EnE 101%;
Deal Comments
Xqujsfhsnfufjm-Bfhwfb Vjjfu. Najfsf Qjjwpqhhfput AQS(Q&L) (YXL), AXQ(Q&L) (BYS), QNS, QVQ. Qsuufsf Qjjwpqhhfput LAY, UXL, SYA, SYV
Guarantor(s)
Kyvj Kjjoojzyxtvzjw Owvxrtovyr Etv
Use of Proceeds
Leqeeeeheez eed zeeewev hxwhxwewe hgwhxkek
Reset
Yes

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan